<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="major coronavirus epidemic of the 21st century after Middle East" exact="respiratory" post="syndrome (MERS) and severe acute respiratory syndrome (SARS). COVID-19"/>
 <result pre="coronavirus epidemic of the 21st century after Middle East respiratory" exact="syndrome" post="(MERS) and severe acute respiratory syndrome (SARS). COVID-19 is"/>
 <result pre="21st century after Middle East respiratory syndrome (MERS) and severe" exact="acute" post="respiratory syndrome (SARS). COVID-19 is not only threatening the"/>
 <result pre="century after Middle East respiratory syndrome (MERS) and severe acute" exact="respiratory" post="syndrome (SARS). COVID-19 is not only threatening the resilience"/>
 <result pre="after Middle East respiratory syndrome (MERS) and severe acute respiratory" exact="syndrome" post="(SARS). COVID-19 is not only threatening the resilience of"/>
 <result pre="raises questions about the world's political and economic-financial future. The" exact="disease" post="phenotypically presents itself in patients who may be asymptomatic"/>
 <result pre="treatment as soon as possible in order to manage the" exact="infection" post="and prevent future epidemics [1], even after the two"/>
 <result pre="management strategies are aimed at reducing the transmission of the" exact="infection" post="and providing support for hospitalized patients. Various drugs have"/>
 <result pre="impact of this virus not only on vulnerable populations with" exact="rheumatic" post="diseases, but also on the population as a whole."/>
 <result pre="population as a whole. We may not be experts in" exact="infectious diseases" post="or coronaviruses, but we do have considerable knowledge and"/>
 <result pre="and anti-IL-1 agents, all of which are indicated in different" exact="rheumatic" post="diseases, and so we are ideally placed to share"/>
 <result pre="scientific community in the search for possible solutions to SARS-Cov2" exact="infection" post="[4]. 1 Anti-malarials As rheumatologists, we are aware of"/>
 <result pre="Their anti-viral effects are related to their ability to limit" exact="viral" post="replication by increasing the endosomal ph required for virus"/>
 <result pre="from China, and the guidelines of the Italian Society for" exact="Infectious" post="and Tropical Diseases (SIMIT) suggest its use in the"/>
 <result pre="the guidelines of the Italian Society for Infectious and Tropical" exact="Diseases" post="(SIMIT) suggest its use in the case of mild"/>
 <result pre="trial of chloroquine found that it did not prevent influenza" exact="infection" post="[5]. 2 Tocilizumab/Sarilumab The clinical presentation of COVID-19 is"/>
 <result pre="dyspnea, nausea, vomiting, diarrhea) to a more severe form of" exact="diffuse" post="interstitial pneumonia(specific radiographic pattern) characterised by neutrophilia, lymphopenia, thrombocytopenia,"/>
 <result pre="radiographic pattern) characterised by neutrophilia, lymphopenia, thrombocytopenia, high levels of" exact="acute" post="phase reactants and inflammatory cytokines, including IL-6,. The acute"/>
 <result pre="of acute phase reactants and inflammatory cytokines, including IL-6,. The" exact="acute" post="respiratory distress syndrome induced by coronavirus infection is associated"/>
 <result pre="acute phase reactants and inflammatory cytokines, including IL-6,. The acute" exact="respiratory" post="distress syndrome induced by coronavirus infection is associated with"/>
 <result pre="reactants and inflammatory cytokines, including IL-6,. The acute respiratory distress" exact="syndrome" post="induced by coronavirus infection is associated with the over-exuberant"/>
 <result pre="including IL-6,. The acute respiratory distress syndrome induced by coronavirus" exact="infection" post="is associated with the over-exuberant release of cytokines (a"/>
 <result pre="cytokines (a â€˜cytokine stormâ€™). In SARS and MERS patients, peak" exact="viral" post="load precedes maximum IL-6 release and subsequent radiographically severe"/>
 <result pre="viral load precedes maximum IL-6 release and subsequent radiographically severe" exact="pneumonia" post="[3]. IL-6 is also a pyrogenic cytokine and, and"/>
 <result pre="and membrane IL-6RÎ± receptors may reduce the severity of the" exact="pulmonary" post="complications of COVID-19, including respiratory failure, but there is"/>
 <result pre="reduce the severity of the pulmonary complications of COVID-19, including" exact="respiratory" post="failure, but there is no evidence that it has"/>
 <result pre="for the Janus kinase inhibitor baricitinib in the treatment of" exact="acute" post="COVID-19 respiratory disease. Viruses infect cells by means of"/>
 <result pre="Janus kinase inhibitor baricitinib in the treatment of acute COVID-19" exact="respiratory" post="disease. Viruses infect cells by means of endocytosis, and"/>
 <result pre="cyclin G-associated kinase (GAK), another regulator of endocytosis, thus blocking" exact="viral" post="entry [9]. Rheumatologists not only know the effectiveness of"/>
 <result pre="their possible adverse effects. The people most affected by SARS-CoV-2" exact="infection" post="are adults aged &amp;gt;60Â years with one or more"/>
 <result pre="of infections, and anti-IL-6 agents have also been associated with" exact="bacterial pneumonia" post="and gastrointestinal perforation [[10], [11], [12], [13], [14], [15],"/>
 <result pre="infections, and anti-IL-6 agents have also been associated with bacterial" exact="pneumonia" post="and gastrointestinal perforation [[10], [11], [12], [13], [14], [15],"/>
 <result pre="3Sarzi-PuttiniP.GiorgiV.SirottiS.MarottoD.ArdizzoneS.RizzardiniG.COVID-19, cytokines and immunosuppression: What can we learn from severe" exact="acute" post="respiratory syndrome?Clin Exp Rheumatol3822020 Mar 2233734232202240 4FerroF.ElefanteE.BaldiniC.BartoloniE.PuxedduI.TalaricoR.COVID-19: the new"/>
 <result pre="cytokines and immunosuppression: What can we learn from severe acute" exact="respiratory" post="syndrome?Clin Exp Rheumatol3822020 Mar 2233734232202240 4FerroF.ElefanteE.BaldiniC.BartoloniE.PuxedduI.TalaricoR.COVID-19: the new challenge"/>
 <result pre="antibody blocking SARS-CoV-2 infectionBiorxiv20203202011.987958 9RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.Baricitinib as potential treatment for 2019-nCoV" exact="acute" post="respiratory diseaseLancet.395102232020 Feb 15e30e3132032529 10ArabiY.M.MandourahY.Al-HameedF.Saudi critical care trial group."/>
 <result pre="blocking SARS-CoV-2 infectionBiorxiv20203202011.987958 9RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory" post="diseaseLancet.395102232020 Feb 15e30e3132032529 10ArabiY.M.MandourahY.Al-HameedF.Saudi critical care trial group. Corticosteroid"/>
 <result pre="group. Corticosteroid therapy for critically ill patients with Middle East" exact="respiratory" post="syndromeAm J Respir Crit Care Med1976201875776729161116 11LeeN.Allen ChanK.C.HuiD.S.Effects of"/>
 <result pre="early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in" exact="adult" post="patientsJ Clin Virol314200430430915494274 12FavalliE.G.IngegnoliF.De LuciaO.CincinelliG.CimazR.CaporaliR.COVID-19 infection and rheumatoid arthritis:"/>
 <result pre="coronavirus RNA concentrations in adult patientsJ Clin Virol314200430430915494274 12FavalliE.G.IngegnoliF.De LuciaO.CincinelliG.CimazR.CaporaliR.COVID-19" exact="infection" post="and rheumatoid arthritis: faraway, so close!Autoimmun Rev202020 Mar102523 13CasoF.CostaL.RuscittiP.NavarinicL.Del"/>
 <result pre="so close!Autoimmun Rev202020 Mar102523 13CasoF.CostaL.RuscittiP.NavarinicL.Del PuenteA.GiacomelliR.Scarpa R could Sars-coronavirus-2 trigger" exact="autoimmune" post="and/or autoinflammatory mechanisms in genetically predisposed subjects?Autoimmun Rev242020 Mar102524"/>
 <result pre="support corticosteroid treatment for 2019-nCoV lung injuryLancet.39510223202047347532043983 15KalilA.C.SunJ.Low-dose steroids for" exact="septic shock" post="and severe sepsis: the use of Bayesian statistics to"/>
</results>
